Ownership history in SHELL ASSET MANAGEMENT CO · 13 quarters on record
This page tracks every 13F SEC filing in which SHELL ASSET MANAGEMENT CO reported a position in ARCTURUS THERAPEUTICS HLDG I (ARCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | REDUCED | 5,282 | -6,767 | -56.2% | 0.00% | $69K | $13.01 |
| 2025 Q1 | REDUCED | 12,049 | -505 | -4.0% | 0.01% | $128K | $10.59 |
| 2024 Q4 | UNCHANGED | 12,554 | — | 0% | 0.01% | $213K | $16.97 |
| 2024 Q3 | REDUCED | 12,554 | -315 | -2.4% | 0.01% | $291K | $23.21 |
| 2024 Q2 | REDUCED | 12,869 | -811 | -5.9% | 0.01% | $313K | $24.35 |
| 2024 Q1 | REDUCED | 13,680 | -3,094 | -18.4% | 0.02% | $462K | $33.77 |
| 2023 Q4 | REDUCED | 16,774 | -5,030 | -23.1% | 0.02% | $529K | $31.53 |
| 2023 Q3 | REDUCED | 21,804 | -377 | -1.7% | 0.02% | $557K | $25.55 |
| 2023 Q2 | REDUCED | 22,181 | -7,517 | -25.3% | 0.03% | $636K | $28.68 |
| 2023 Q1 | ADDED | 29,698 | +13,843 | +87.3% | 0.03% | $712K | $23.97 |
As of 2025 Q4 — sorted by position size